Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsed Intravenous Methylprednisolone for Ocular Pemphigoid – Pilot Study
2005-002391-14Phase 4Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of methylprednisolone in ocular cicatricial pemphigoid (OCP), sponsored by Moorfields Eye Hospital. Primary endpoint: Control of ocular inflammation at 2 months. Started Aug 2005; status: completed.
02
Drugs
methylprednisolone
03
Conditions
ocular cicatricial pemphigoid (OCP)
Beyond the preview
Go deeper on 2005-002391-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002391-14.